TABLE 1.
Partner Treated† (n = 37) | Partner Not Treated† (n = 14) | P ‡ | |
---|---|---|---|
Demographic and relationship characteristics | |||
Age, median (IQR), y | 22 (20–27) | 23 (21–24) | 0.88 |
Years of school completed, median (IQR) | 8 (7–8) | 8 (7–8) | 0.54 |
Married, n (%) | 33 (89) | 11 (79) | 0.33 |
Marriage type, n (%) | |||
Monogamous | 31 (94) | 10 (91) | 0.73 |
Polygamous | 2 (6) | 1 (9) | |
Any reported intimate partner violence, last month, n (%) | 0 (0) | 2 (14) | 0.02 |
Reports feeling unsafe in relationship | 0 (0) | 1 (7) | 0.10 |
Sexual behavior | |||
Age of sexual debut, median (IQR), y | 16 (14–18) | 15 (15–17) | 0.86 |
No. sexual partners, lifetime, median (IQR) | 3 (2–3) | 3 (1–4) | 0.90 |
Coital frequency, past month, median (IQR) | 2 (0–3) | 1 (0–2) | 0.35 |
Reported unprotected sex, past month§, n (%) | 23 (66) | 7 (50) | 0.31 |
Medical characteristics | |||
Parity, median (IQR) | 2 (1–4) | 2 (1–3) | 0.88 |
Gestational age of enrollment pregnancy, median (IQR) | 26 (21–30) | 27 (25–39) | 0.04 |
Laboratory diagnosis of STI at screening∥, n (%) | |||
GC | 5 (14) | 3 (21) | 0.49 |
CT | 5 (14) | 1 (7) | 0.53 |
TV | 27 (73) | 10 (71) | 0.91 |
Reported fears or barriers to PDPT | |||
Feared partner’s anger or abuse, n (%) | 2 (5) | 1 (8) | 0.75 |
Feared accusations of being STI source, n (%) | 1 (3) | 2 (15) | 0.09 |
Feared accusations of promiscuity, n (%) | 1 (3) | 0 (0) | 0.56 |
Feared stigma associated with STIs, n (%) | 0 (0) | 1 (8) | 0.08 |
Partner lived far away, n (%) | 0 (0) | 3 (23) | 0.002 |
Clinical outcomes following PDPT acceptance or declination | |||
Subsequent reinfection¶**, n (%) | |||
GC | 0/5 (0) | 0/3 (0) | — |
CT | 0/4 (0) | 1/1 (100) | 0.167 |
TV | 4/25 (16) | 2/9 (22) | 0.606 |
Missing data not shown; demographic, relationship, medical, and sexual behavior characteristics as reported at
Partner treated defined as those screened for PDPT who were willing to deliver treatment to male partners and reported successful PDPT delivery. Partner not treated defined as those screened for PDPT who were not willing to deliver treatment to male partners or did not report successful PDPT deliver.
χ2 Test and Kruskal-Wallis test with Fisher exact P value.
Among participants who reported sexual intercourse in the past month.
All women were administered treatment at the same visit as STI detection or subsequent follow-up visit.
Subsequent reinfection defined as infection detected at least 30 days after documented treatment administration.
Four women were not reassessed for subsequent infections: 3 partner treated (2 with TV infections before PDPT administration; 1 with CT) and 1 partner not treated (with TV infection before PDPT participation screening).
IQR indicates interquartile range.